CLASS II Drug recall · Reported 15 Mar 2017 · FDA Enforcement Report
Aspirin Chewable Tablets, 81 mg, (Nsaid*) recalled
Mckesson Packaging Services is recalling Aspirin Chewable Tablets, 81 mg, (Nsaid*), distributed nationwide in the US. The recall was initiated on 23 Feb 2017 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0513-2017
- FDA event ID
- 76631
- Recalling firm
- Mckesson Packaging Services, Concord, NC
- Classification
- Class II
- Status
- Completed
- Recall initiated
- 23 Feb 2017
- FDA classified
- 7 Mar 2017
- Reported
- 15 Mar 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Foreign Material
- Drug class
- Pain Medication
Timeline
| 23 Feb 2017 | Recall initiated by company | |
| 7 Mar 2017 | Classified by FDA | +12 days |
| 15 Mar 2017 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Foreign Substance: foreign material found in the bulk inventory.
Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.
Product as listed by the FDA
Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
Presence of Foreign Substance: foreign material found in the bulk inventory.
Which lots are affected?
Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Mckesson Packaging Services
All 17| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Diltiazem HCl Extended-Release Capsules, USP 120 mg recalled | Mckesson Packaging Services | Potency & Assay | Nationwide |
| Drug | CLASS III | Diltiazem HCl Extended-Release Capsules, USP 240 mg recalled | Mckesson Packaging Services | Potency & Assay | Nationwide |
| Drug | CLASS III | Diltiazem CD (Diltiazem Hydrochloride Extended-Release recalled | Mckesson Packaging Services | Potency & Assay | Nationwide |
| Drug | CLASS II | Ranitidine Tablets, USP 150 mg UD recalled | Mckesson Packaging Services | Potency & Assay | Nationwide |
| Drug | CLASS III | Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes recalled | Mckesson Packaging Services | Potency & Assay | Nationwide |
Other Aspirin recalls
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Aspirin Chewable tablet 81 mg recalled by Safecor HealthAspirin | Safecor Health | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Low Dose Aspirin, 81 mg recalled by Cardinal HealthcareAspirin | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Aspirin and Extended-release Dipyridamole Capsules recalled | American Health Packaging | Potency & Assay | Nationwide |
| Drug | CLASS II | Aspirin/ER Dipyridamole, Capsule, 25 mg/200 mg recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Aspirin, Chew Tablet, 81 mg, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |